Samjin Pharmaceutical Executive Park Chang-ik Buys 2,000 Shares, Slight Stake Increase and Share Cancellation Positive
Samjin Pharmaceutical non-registered executive Park Chang-ik acquired an additional 2,000 common shares at 18,050 KRW per share through open market purchase on April 13, 2026.
His total holdings increased from 5,000 to 7,000 shares, raising his ownership ratio slightly from 0.04% to 0.05%.
The total outstanding shares decreased from 13,900,000 to 13,320,000 due to a treasury stock retirement on November 25, 2025, enhancing shareholder value.
Although the insider purchase is small in size, it is interpreted as a shareholder-friendly signal along with the share cancellation.
[AI Summary]The small insider purchase combined with the share cancellation provides limited positive factors for the stock price. The financial impact is minimal, but it indirectly reflects management's confidence in the company's value.
KOSPI Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders